Physician profile
Deborah L Smith
NPI 1073616926
$2,507.24
in general payments reported to CMS, 2019-2025
13 companies · $72.17 in 2025
The $72.17 reported for 2025 was less than what a typical Reproductive Endocrinology provider received nationally (typical 2025 total: $140).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $466 · 2020: $1,154 · 2021: $349 · 2022: $191 · 2023: $155 · 2024: $119 · 2025: $72.17.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $347.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $346.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $1,553.53 | 2019-2025 | Menopur |
| Organon LLC | $458.37 | 2021-2025 | Follistim Aq |
| Abbvie INC. | $135.82 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $118.64 | 2019-2020 | |
| Coopersurgical, INC. | $63.60 | 2021-2022 | |
| Hologic Sales and Service, LLC | $32.74 | 2019-2021 | |
| Meditrina | $26.88 | 2021 | |
| Janssen Biotech, INC. | $25.42 | 2019 | |
| Olympus America INC. | $25.21 | 2019 | |
| Medtronic, INC. | $19.52 | 2021 | |
| Covidien LP | $16.34 | 2019 | |
| Cook Medical LLC | $15.82 | 2019 | |
| Beigene USA, INC. | $15.35 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deborah Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.